Semnur Pharmaceuticals, Inc.
SMNR
$8.00
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5,194.10% | 5,328.21% | 21.17% | 62.81% | 81.83% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3,320.38% | 3,101.53% | -16.43% | -5.31% | 43.82% |
| Operating Income | -3,320.38% | -3,101.53% | 16.43% | 5.31% | -43.82% |
| Income Before Tax | -3,320.38% | -3,101.53% | 16.43% | 5.31% | -43.82% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3,320.38% | -3,101.53% | 16.43% | 5.31% | -43.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3,320.38% | -3,101.53% | 16.43% | 5.31% | -43.82% |
| EBIT | -3,320.38% | -3,101.53% | 16.43% | 5.31% | -43.82% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -2,878.65% | -2,595.45% | 25.45% | 15.35% | -30.88% |
| Normalized Basic EPS | -2,876.65% | -2,591.62% | 25.29% | 15.19% | -32.54% |
| EPS Diluted | -2,878.65% | -2,595.45% | 25.45% | 15.35% | -30.88% |
| Normalized Diluted EPS | -2,876.65% | -2,591.62% | 25.29% | 15.19% | -32.54% |
| Average Basic Shares Outstanding | 2.66% | 6.13% | 12.50% | 12.50% | 12.50% |
| Average Diluted Shares Outstanding | 2.66% | 6.13% | 12.50% | 12.50% | 12.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |